Clinical Trials Browser

Phase 1 × avelumab × Other hematologic neoplasm × Clear all

NCT03395873 2019-08-21

Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute